Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 17:51
Grifols 1 Year Total Returns (Daily): 2.02% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | 2.02% |
November 12, 2024 | 2.13% |
November 11, 2024 | 4.60% |
November 08, 2024 | 3.94% |
November 07, 2024 | 4.28% |
November 06, 2024 | -1.20% |
November 05, 2024 | -0.21% |
November 04, 2024 | -5.48% |
November 01, 2024 | 9.27% |
October 31, 2024 | 7.42% |
October 30, 2024 | 11.58% |
October 29, 2024 | 4.59% |
October 28, 2024 | 6.38% |
October 25, 2024 | 12.50% |
October 24, 2024 | 9.65% |
October 23, 2024 | 11.63% |
October 22, 2024 | 9.02% |
October 21, 2024 | 5.93% |
October 18, 2024 | 1.17% |
October 17, 2024 | -2.05% |
October 16, 2024 | -2.86% |
October 15, 2024 | -3.30% |
October 14, 2024 | -2.50% |
October 11, 2024 | -2.61% |
October 10, 2024 | -1.48% |
Date | Value |
---|---|
October 09, 2024 | 1.64% |
October 08, 2024 | 1.74% |
October 07, 2024 | 3.14% |
October 04, 2024 | 2.65% |
October 03, 2024 | 5.79% |
October 02, 2024 | -1.89% |
October 01, 2024 | -3.39% |
September 30, 2024 | -2.84% |
September 27, 2024 | -1.54% |
September 26, 2024 | -4.04% |
September 25, 2024 | -5.77% |
September 24, 2024 | -7.45% |
September 23, 2024 | -6.38% |
September 20, 2024 | -7.25% |
September 19, 2024 | -6.87% |
September 18, 2024 | -11.90% |
September 17, 2024 | -10.01% |
September 16, 2024 | -6.57% |
September 13, 2024 | -5.12% |
September 12, 2024 | -6.08% |
September 11, 2024 | 0.22% |
September 10, 2024 | -5.82% |
September 09, 2024 | -4.03% |
September 06, 2024 | -7.52% |
September 05, 2024 | -4.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-60.12%
Minimum
Sep 29 2022
53.61%
Maximum
Sep 29 2023
-13.24%
Average
-16.00%
Median
1 Year Total Returns (Daily) Benchmarks
Cellectis SA | -22.22% |
Adaptimmune Therapeutics PLC | 62.55% |
Akari Therapeutics PLC | -34.12% |
Biodexa Pharmaceuticals PLC | -91.74% |
Verona Pharma PLC | 159.4% |